New cancer clinical trial: An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer

Published on: January 31, 2018 at 12:00PM
Conditions:   Lung Cancer;   Non-Small Cell Lung Cancer
Interventions:   Drug: BMS-986205;   Biological: Nivolumab;   Drug: Chemotherapy
Sponsor:   Bristol-Myers Squibb
Not yet recruiting
http://ift.tt/2EsQsra